← Back to patent-cliff list
Heparin calcium
Tier C — Watch / tradeHeparin calcium
Sanofi
Originator
2000
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：SERPINC1
Brand：Calciparine
Indications (approved)：Venous thromboembolism, 血液凝固障碍
Regional status
US
No progress
1998-02-01
EU
-
China
Approved
2000-12-07
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Heparin calcium?
Approved indications include: Venous thromboembolism, 血液凝固障碍.
When does the Heparin calcium patent expire?
No public expiry year is available for Heparin calcium yet; this page updates once verified.
How do I get a quote for Heparin calcium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04